Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma (Q68891168)
scientific article published on 01 September 1990
Language:
(P31) (Q13442814)
(P304) 1397-1402
(P407) (Q1860)
(P433) 17
(P478) 82
(P577) Saturday, September 1, 1990
(P921) (Q1164529)
(P1433) (Q400279)
(P1476) "Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma" (language: en)
(P2093) E R Gaynor
G R Weiss
K A Margolin
F R Aronson
M Sznol
P Demchak
K M Grima
R I Fisher
D H Boldt
J H Doroshow
other details
description scientific article published on 01 September 1990

External Links